Biological role and clinicopathological significance of leucine-rich α-2 glycoprotein 1 in the glioblastoma microenvironment
Journal of Neuropathology & Experimental Neurology · 2025
DOI: 10.1093/jnen/nlaf049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2025. Verfasst von Takuya Furuta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Kurume University School of Medicine, Kurume, Japan. Hauptthemen laut MEDLINE: Glioblastoma, Tumor Microenvironment, Brain Neoplasms, Glycoproteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Japanese Ministry of Education, Science, Sports, Technology and Culture, Grant-in-Aids for Scientific Research.
Abstract (Originalsprache)
Pseudoprogression, often misinterpreted as glioblastoma progression on MRI, results from treatment-induced inflammation and can resolve without additional intervention. This study investigated the role of leucine-rich α-2 glycoprotein 1 (LRG1) in the glioblastoma microenvironment. Leucine-rich α-2 glycoprotein 1 is associated with inflammation and prognosis in various diseases and its blood concentrations reflect disease-related inflammation. We focused on LRG1 expression in reactive astrocytes and assessed its potential as a biomarker for glioblastoma pseudoprogression. Cases with high LRG1 expression exhibited a distinct molecular profile, with increased angiogenesis-related gene expression and reduced stem cell-related gene activity, underscoring its dual role in tumor biology and progression. In vitro experiments demonstrated that LRG1 suppressed tumor cell invasion, supporting its inverse correlation with tumor cell stemness. Immunohistochemical analysis revealed that astrocytic LRG1 was associated with heightened peritumoral inflammation, characterized by CD8+ T-cell infiltration at the tumor periphery; this correlated with higher pseudoprogression rates and poorer prognosis. By providing a histopathological marker for pseudoprogression, LRG1 complements current imaging modalities and offers a novel approach to addressing unresolved diagnostic challenges in glioblastoma. These findings establish LRG1 as a promising biomarker that could aid clinicians in distinguishing pseudoprogression from true progression, ultimately enhancing personalized treatment strategies for glioblastoma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
- Department of Occupational Therapy, Kanazawa University School of Medicine, Kanazawa, Japan.
- Department of Neurosurgery, Kurume University School of Medicine, Kurume, Japan.
- Department of Molecular Systems Pharmaceutics, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.
- Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
- Department of Neurosurgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.
ORCID-Profile: Takuya Furuta, Yasuo Uchida
Förderung
- Japanese Ministry of Education, Science, Sports, Technology and Culture
- Grant-in-Aids for Scientific Research
Zitieren
APA
Furuta, T., Miyoshi, H., Moritsubo, M., Nakajima, R., Negoto, T., Nakamura, H., Morioka, M., Uchida, Y., Ohtsuki, S., & Nakada, M. (2025). Biological role and clinicopathological significance of leucine-rich α-2 glycoprotein 1 in the glioblastoma microenvironment. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlaf049
Vancouver
Furuta T, Miyoshi H, Moritsubo M, Nakajima R, Negoto T, Nakamura H, et al. Biological role and clinicopathological significance of leucine-rich α-2 glycoprotein 1 in the glioblastoma microenvironment. Journal of Neuropathology & Experimental Neurology. 2025. doi:10.1093/jnen/nlaf049
BibTeX
@article{Furuta2025,
author = {Furuta, Takuya and Miyoshi, Hiroaki and Moritsubo, Mayuko and Nakajima, Riho and Negoto, Tetsuya and Nakamura, Hideo and Morioka, Motohiro and Uchida, Yasuo and Ohtsuki, Sumio and Nakada, Mitsutoshi},
title = {Biological role and clinicopathological significance of leucine-rich α-2 glycoprotein 1 in the glioblastoma microenvironment},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2025},
doi = {10.1093/jnen/nlaf049}
}
EUVIMED